BFA
RIGL icon

BlackRock Fund Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

BlackRock Fund Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$10.4M Buy
438,231
+54,463
+14% +$1.56M ﹤0.01% 2549
2016
Q3 		$14.1M Buy
383,768
+26,195
+7% +$751K ﹤0.01% 2261
2016
Q2 		$7.97M Buy
357,573
+14,787
+4% +$368K ﹤0.01% 2535
2016
Q1 		$7.13M Buy
342,786
+5,213
+2% +$129K ﹤0.01% 2552
2015
Q4 		$10.2M Buy
337,573
+109,991
+48% +$3.33M ﹤0.01% 2429
2015
Q3 		$5.62M Sell
227,582
-2,643
-1% -$78.9K ﹤0.01% 2732
2015
Q2 		$7.39M Sell
230,225
-7,037
-3% -$269K ﹤0.01% 2680
2015
Q1 		$8.47M Sell
237,262
-3,057
-1% -$83.8K ﹤0.01% 2529
2014
Q4 		$5.46M Sell
240,319
-76,629
-24% -$1.55M ﹤0.01% 2826
2014
Q3 		$6.15M Sell
316,948
-8,801
-3% -$249K ﹤0.01% 2622
2014
Q2 		$11.8M Sell
325,749
-24,448
-7% -$831K ﹤0.01% 2318
2014
Q1 		$13.6M Buy
350,197
+8,392
+2% +$299K ﹤0.01% 2220
2013
Q4 		$9.74M Sell
341,805
-75,534
-18% -$2.22M ﹤0.01% 2409
2013
Q3 		$14.9M Buy
417,339
+31,991
+8% +$1.17M 0.01% 2120
2013
Q2 		$12.9M Buy
+385,348
New +$17.5M ﹤0.01% 2117

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock Fund Advisors's RIGL Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Rigel Pharmaceuticals (RIGL) stake by 14% in Q4 2016, buying an estimated $1.56M and bringing the position to 438,231 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

BlackRock Fund Advisors first reported a position in RIGL in Q2 2013 and has held it in 15 quarters since. The position peaked at $14.9M in Q3 2013. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • BlackRock Fund Advisors held 438,231 shares of Rigel Pharmaceuticals worth $10.4M as of Q4 2016.
  • BlackRock Fund Advisors bought 54,463 Rigel Pharmaceuticals shares in Q4 2016, an estimated $1.56M.
  • Rigel Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2549 holding.
  • BlackRock Fund Advisors first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Rigel Pharmaceuticals position peaked at $14.9M in Q3 2013.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.